The fundraise proposal from one of India's largest private life insurers comes ahead of full-year results, with the insurer's chief executive pointing to sustained momentum heading into FY2027.
Despite the weaker Asia performance, the reinsurer is eyeing expansion into China, India, and Southeast Asia under its new VIGRe28 strategy, as it prepares to open a Singapore office.
The development highlights ongoing regulatory efforts to address cost pressures and execution challenges in India’s rapidly growing private health insurance market.
